Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1133367
PUBLISHER: Grand View Research | PRODUCT CODE: 1133367
Transthyretin Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Type (ATTR-PN, ATTR-CM), By Therapy, By Disease Type, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Transthyretin Amyloidosis Treatment Market Growth & Trends:
The global transthyretin amyloidosis treatment market size is expected to reach USD 9.17 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.6% from 2022 to 2030. The transthyretin amyloidosis treatment market is mainly driven by the presence of supportive reimbursement programs and the growing African American population. The increasing African American population acted as a catalyst for the industry growth throughout the period owing to the high susceptibility to ATTR amyloidosis. The Val122Ile is the most prevalent mutation worldwide that leads to cardiomyopathy among the population specific to aged 65 years and above. Furthermore, this Val122Ile mutation is present in 3% to 4% of the African American population worldwide.
An increase in research activities for the development of novel diagnostic techniques and multidisciplinary therapeutic approaches is expected to lead to an increased survival rate and a more favorable prognosis of transthyretin amyloidosis. For instance, in November 2019, the Amyloidosis Research Consortium developed a disease-specific patient-reported outcome (PRO) tool to understand and measure the impact of transthyretin amyloidosis from the patient perspective. An introduction of such a tool will boost the research in developing a new target-specific drug by understanding disease complexity and patients' need, thereby widening the opportunity in the transthyretin amyloidosis treatment market.
Strategic initiatives undertaken by major players such as creating awareness regarding the target conditions such as ATTR and the long-term benefits of available therapies are expected to fuel industry growth. For instance, in 2019, Pfizer, Inc., in collaboration with the World Heart Federation, started the "Heart Hero" campaign. Under this campaign, Pfizer, Inc. provides educational information and resources related to ATTR-CM to patients and physicians. Such campaigns are expected to boost the early diagnosis of the disease and increase the treatment rate over time.
The movement undertaken by key players to provide free-of-cost medicine under their CSR activities is also projected to fuel market growth. For instance, the Pfizer Patient Assistance Program provides Pfizer medicines such as VYNDAMAX free of cost to eligible patients. People diagnosed with amyloidosis can take advantage of such programs by enrolling at the Vandalink platform. Such programs are expected to encourage physicians to prescribe this drug to a patient as drug therapy in transthyretin amyloidosis patients.
Transthyretin Amyloidosis Treatment Market Report Highlights:
- By type, the ATTR-CM accounted for a leading share in 2021 owing to the high prevalence of the disease and the rising geriatric population. The ATTR-PN is expected to exhibit the fastest growth rate throughout the forecast period. The segment growth is attributed to the presence of a strong pipeline
- By therapy, the targeted therapy segment grabbed a dominant share in 2021 owing to the worldwide approval of the therapies and the growing prescription rate for the treatment of ATTR-CM
- By disease type, the hereditary transthyretin amyloidosis segment dominated the market in 2021 owing to growing strategic alliances among various pharmaceutical companies aiming toward drug development along with growing pipeline drugs
- By distribution channel, the hospital pharmacies captured the largest share in 2021 as most of the hospitals are working toward the diagnosis, research, and treatment of transthyretin amyloidosis
- North America region held the largest share in 2021 owing to the increasing novel drug prescription, proper reimbursement policies, and higher treatment rates in the region
- The MEA region is expected to exhibit the fastest growth rate throughout the forecast period. The segment growth is attributed to the increasing incidence of ATTR amyloidosis
Product Code: GVR-4-68039-977-9
Report SummaryTable of ContentsSegmentationMethodologyRequest a FREE Sample Copy
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Competition Milieu
- 1.3. Segment Outlook
Chapter 2. Research Methodology
- 2.1. Information Procurement
- 2.2. Information or Data Analysis
- 2.3. Market Formulation & Validation
Chapter 3. Transthyretin Amyloidosis Treatment Market Variables, Trends & Scope
- 3.1. Parent Market Analysis
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing incidences of diseases
- 3.2.1.2. Increasing geriatric population
- 3.2.1.3. Robust pipeline of ATTR drug therapies
- 3.2.1.4. Rising awareness about diseases
- 3.2.2. Market restraint analysis
- 3.2.2.1. Misdiagnosis of the disease
- 3.2.2.2. High cost of treatment
- 3.2.1. Market driver analysis
Chapter 4. Transthyretin Amyloidosis Treatment Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 4.1. Definitions & Scope
- 4.2. Global Transthyretin Amyloidosis Treatment Market, By Type, 2018 - 2030 (USD Million)
- 4.3. Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
- 4.3.1. ATTR-PN
- 4.3.1.1. Global Transthyretin Amyloidosis Treatment Market, ATTR-PN, 2018 - 2030 (USD Million)
- 4.3.2. ATTR-CM
- 4.3.2.1. Global Transthyretin Amyloidosis Treatment Market, ATTR-CM, 2018 - 2030 (USD Million)
- 4.3.1. ATTR-PN
Chapter 5. Transthyretin Amyloidosis Treatment Market: Segment Analysis, By Therapy, 2018 - 2030 (USD Million)
- 5.1. Definitions & Scope
- 5.2. Global Transthyretin Amyloidosis Treatment Market, By Therapy, 2018 - 2030 (USD Million)
- 5.3. Market Size & Forecasts and Trend Analyses, 2018 - 2030
- 5.3.1. Targeted Therapy
- 5.3.1.1. Global Transthyretin Amyloidosis Treatment Market, Targeted Therapy, 2018 - 2030 (USD Million)
- 5.3.2. Supportive Therapy
- 5.3.2.1. Global Transthyretin Amyloidosis Treatment Market, Supportive Therapy, 2018 - 2030 (USD Million)
- 5.3.3. Pipeline Therapy
- 5.3.3.1. Global Transthyretin Amyloidosis Treatment Market, Pipeline Therapy, 2018 - 2030 (USD Million)
- 5.3.1. Targeted Therapy
Chapter 6. Transthyretin Amyloidosis Treatment Market: Segment Analysis, By Disease Type, 2018 - 2030 (USD Million)
- 6.1. Definitions & Scope
- 6.2. Global Transthyretin Amyloidosis Treatment Market, By Disease Type, 2018 - 2030 (USD Million)
- 6.3. Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
- 6.3.1. Hereditary Transthyretin Amyloidosis
- 6.3.1.1. Global Transthyretin Amyloidosis Treatment Market, Hereditary Transthyretin Amyloidosis Treatment Market , 2018 - 2030 (USD Million)
- 6.3.1.2. Polyneuropathy
- 6.3.1.2.1. Global Transthyretin Amyloidosis Treatment Market , Polyneuropathy Market, 2018 - 2030 (USD Million)
- 6.3.1.3. Cardiomyopathy
- 6.3.1.3.1. Global Transthyretin Amyloidosis Treatment Market, Cardiomyopathy Market, 2018 - 2030 (USD Million)
- 6.3.1.4. Mixed Type
- 6.3.1.4.1. Global Transthyretin Amyloidosis Treatment Market, Mixed Type Market, 2018 - 2030 (USD Million)
- 6.3.2. Wild Type Amyloidosis
- 6.3.2.1. Global Transthyretin Amyloidosis Treatment Market, Wild Type Amyloidosis Market, 2018 - 2030 (USD Million)
- 6.3.1. Hereditary Transthyretin Amyloidosis
Chapter 7. Transthyretin Amyloidosis Treatment Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
- 7.1. Definitions & Scope
- 7.2. Global Transthyretin Amyloidosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
- 7.3. Market Size & Forecasts and Trend Analyses, 2018 - 2030 (USD Million)
- 7.3.1. Hospital Pharmacies
- 7.3.1.1. Global Transthyretin Amyloidosis Treatment Market, Hospital Pharmacies, 2018 - 2030 (USD Million)
- 7.3.2. Specialty Pharmacies
- 7.3.2.1. Global Transthyretin Amyloidosis Treatment Market, Specialty Pharmacies, 2018 - 2030 (USD Million)
- 7.3.3. Retail Pharmacies
- 7.3.3.1. Global Transthyretin Amyloidosis Treatment Market, Retail Pharmacies, 2018 - 2030 (USD Million)
- 7.3.4. Online Pharmacies
- 7.3.4.1. Global Transthyretin Amyloidosis Treatment Market, Online Pharmacies, 2018 - 2030 (USD Million)
- 7.3.1. Hospital Pharmacies
Chapter 8. Transthyretin Amyloidosis Treatment Market: Regional Market Analysis, By Region, 2018 - 2030 (USD Million)
- 8.1. Definitions & Scope
- 8.2. Regional Market Share Analysis, 2021&2030
- 8.3. Regional Market Dashboard
- 8.4. Regional Market: Key Players
- 8.5. Market Size, & Forecasts, and Trend Analysis, 2021 to 2030:
- 8.6. North America
- 8.6.1. North America market estimates and forecast, 2018 - 2030 (USD Million)
- 8.6.2. U.S.
- 8.6.2.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 8.6.3. Canada
- 8.6.3.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 8.7. Europe
- 8.7.1. Europe market estimates and forecast, 2018 - 2030 (USD Million)
- 8.7.2. Germany
- 8.7.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 8.7.3. U.K.
- 8.7.3.1. U.K. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.7.4. France
- 8.7.4.1. France market estimates and forecast, 2018 - 2030 (USD Million)
- 8.7.5. Italy
- 8.7.5.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 8.7.6. Spain
- 8.7.6.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 8.7.7. Russia
- 8.7.7.1. Russia market estimates and forecast, 2018 - 2030 (USD Million)
- 8.8. Asia Pacific
- 8.8.1. Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
- 8.8.2. Japan
- 8.8.2.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 8.8.3. Australia
- 8.8.3.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 8.8.4. India
- 8.8.4.1. India market estimates and forecast, 2018 - 2030 (USD Million)
- 8.8.5. China
- 8.8.5.1. China market estimates and forecast, 2018 - 2030 (USD Million)
- 8.8.6. Singapore
- 8.8.6.1. Singapore market estimates and forecast, 2018 - 2030 (USD Million)
- 8.9. Latin America
- 8.9.1. Latin America market estimates and forecast, 2018 - 2030 (USD Million)
- 8.9.2. Mexico
- 8.9.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 8.9.3. Brazil
- 8.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.9.4. Argentina
- 8.9.4.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 8.10. Middle East & Africa
- 8.10.1. Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 8.10.2. South Africa
- 8.10.2.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 8.10.3. Saudi Arabia
- 8.10.3.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 8.10.4. UAE
- 8.10.4.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Strategy Framework
- 9.2. Market Participation Categorization
- 9.3. Company Profile
- 9.3.1. Pfizer Inc.
- 9.3.1.1. Company Overview
- 9.3.1.2. Financial Performance
- 9.3.1.3. Product Benchmarking
- 9.3.1.4. Strategic Initiatives
- 9.3.2. Johnson & Johnson Services, Inc.
- 9.3.2.1. Company Overview
- 9.3.2.2. Financial Performance
- 9.3.2.3. Product Benchmarking
- 9.3.2.4. Strategic Initiatives
- 9.3.3. Ionis Pharmaceuticales, Inc.
- 9.3.3.1. Company Overview
- 9.3.3.2. Financial Performance
- 9.3.3.3. Product Benchmarking
- 9.3.3.4. Strategic Initiatives
- 9.3.4. Alnylam Pharmaceuticals, Inc.
- 9.3.4.1. Company Overview
- 9.3.4.2. Financial Performance
- 9.3.4.3. Product Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. BridgeBio Pharma, Inc.
- 9.3.5.1. Company Overview
- 9.3.5.2. Financial Performance
- 9.3.5.3. Product Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. Bristol-Myers Squibb Company
- 9.3.6.1. Company Overview
- 9.3.6.2. Financial Performance
- 9.3.6.3. Product Benchmarking
- 9.3.6.4. Strategic Initiatives
- 9.3.7. Acrotech Biopharma
- 9.3.7.1. Company Overview
- 9.3.7.2. Financial Performance
- 9.3.7.3. Product Benchmarking
- 9.3.7.4. Strategic Initiatives
- 9.3.8. Astrazeneca
- 9.3.8.1. Company Overview
- 9.3.8.2. Financial Performance
- 9.3.8.3. Product Benchmarking
- 9.3.8.4. Strategic Initiatives
- 9.3.9. Astellas Pharma, Inc.
- 9.3.9.1. Company Overview
- 9.3.9.2. Financial Performance
- 9.3.9.3. Product Benchmarking
- 9.3.9.4. Strategic Initiatives
- 9.3.10. Prothena
- 9.3.10.1. Company Overview
- 9.3.10.2. Financial Performance
- 9.3.10.3. Product Benchmarking
- 9.3.10.4. Strategic Initiatives
- 9.3.11. SOM Biotech
- 9.3.11.1. Company Overview
- 9.3.11.2. Financial Performance
- 9.3.11.3. Product Benchmarking
- 9.3.11.4. Strategic Initiatives
- 9.3.1. Pfizer Inc.
Product Code: GVR-4-68039-977-9
List of Tables
- Table 1 List of Tables
- Table 2 List of Secondary Sources
- Table 3 List of Abbreviations
- Table 4 Global Transthyretin Amyloidosis Treatment Market, by Region, 2018 - 2030 (USD Million)
- Table 5 Global Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 6 Global Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 7 Global Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 8 Global Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 9 Global Transthyretin Amyloidosis Treatment Market, by Region, 2018 - 2030 (USD Million)
- Table 10 North America Transthyretin Amyloidosis Treatment Market, by Country, 2018 - 2030 (USD Million)
- Table 11 North America Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 12 North America Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 13 North America Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 14 North America Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 15 U.S. Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 16 U.S. Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 17 U.S. Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 18 U.S. Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 19 Canada Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 20 Canada Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 21 Canada Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 22 Canada Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 23 Europe Transthyretin Amyloidosis Treatment Market, by Country, 2018 - 2030 (USD Million)
- Table 24 Europe Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 25 Europe Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 26 Europe Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 27 Europe Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 28 Germany Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 29 Germany Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 30 Germany Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 31 Germany Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 32 U.K. Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 33 U.K. Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 34 U.K. Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 35 U.K. Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 36 France Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 37 France Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 38 France Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 39 France Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 40 Italy Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 41 Italy Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 42 Italy Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 43 Italy Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 44 Spain Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 45 Spain Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 46 Spain Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 47 Spain Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 48 Asia Pacific Transthyretin Amyloidosis Treatment Market, by Country, 2018 - 2030 (USD Million)
- Table 49 Asia Pacific Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 50 Asia Pacific Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 51 Asia Pacific Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 52 Asia Pacific Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 53 China Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 54 China Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 55 China Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 56 China Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 57 Japan Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 58 Japan Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 59 Japan Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 60 Japan Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 61 India Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 62 India Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 63 India Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 64 India Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 65 Australia Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 66 Australia Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 67 Australia Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 68 Australia Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 69 Singapore Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 70 Singapore Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 71 Singapore Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 72 Singapore Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 73 Latin America Transthyretin Amyloidosis Treatment Market, by Country, 2018 - 2030 (USD Million)
- Table 74 Latin America Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 75 Latin America Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 76 Latin America Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 77 Latin America Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 78 Brazil Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 79 Brazil Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 80 Brazil Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 81 Brazil Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 82 Mexico Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 83 Mexico Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 84 Mexico Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 85 Mexico Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 86 Argentina Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 87 Argentina Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 88 Argentina Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 89 Argentina Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 90 Middle East & Africa Transthyretin Amyloidosis Treatment Market, by Country, 2018 - 2030 (USD Million)
- Table 91 Middle East & Africa Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 92 Middle East & Africa Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 93 Middle East & Africa Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 94 Middle East & Africa Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 95 South Africa Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 96 South Africa Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 97 South Africa Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 98 South Africa Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 99 Saudi Arabia Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 100 Saudi Arabia Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 101 Saudi Arabia Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 102 Saudi Arabia Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
- Table 103 UAE Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Million)
- Table 104 UAE Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Million)
- Table 105 UAE Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 106 UAE Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
- Figure 1 Market research process
- Figure 2 Information procurement
- Figure 3 Primary research pattern
- Figure 4 Market research approaches
- Figure 5 Value chain-based sizing & forecasting
- Figure 6 Market formulation & validation
- Figure 7 Transthyretin amyloidosis market segmentation
- Figure 8 Market driver relevance analysis (Current & future impact)
- Figure 9 Market restraint relevance analysis (Current & future impact)
- Figure 10 Market challenge relevance analysis (Current & future impact)
- Figure 11 Penetration & growth prospect mapping
- Figure 12 SWOT analysis, by factor (political & legal, economic, and technological)
- Figure 13 Porter's five forces analysis
- Figure 14 Market penetration vs growth prospect mapping
- Figure 15 Transthyretin Amyloidosis Treatment Market: Type Movement Analysis
- Figure 16 ATTR-PN Market, 2018 - 2030 (USD Million)
- Figure 17 ATTR-CM Market, 2018 - 2030 (USD Million)
- Figure 18 Transthyretin Amyloidosis Treatment Market: Therapy Movement Analysis
- Figure 19 Targeted Therapy Market, 2018 - 2030 (USD Million)
- Figure 20 Supportive Therapy Market, 2018 - 2030 (USD Million)
- Figure 21 Pipeline Therapy Market, 2018 - 2030 (USD Million)
- Figure 22 Transthyretin Amyloidosis Treatment Market: Disease Type Movement Analysis
- Figure 23 Hereditary Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 24 Wild Type Amyloidosis Market, 2018 - 2030 (USD Million)
- Figure 25 Transthyretin Amyloidosis Treatment Market: Distribution Channel Movement Analysis
- Figure 26 Hospital Pharmacies Amyloidosis Market, 2018 - 2030 (USD Million)
- Figure 27 Specialty Pharmacies Amyloidosis Market, 2018 - 2030 (USD Million)
- Figure 28 Retail Pharmacies Amyloidosis Market, 2018 - 2030 (USD Million)
- Figure 29 Online Pharmacies Amyloidosis Market, 2018 - 2030 (USD Million)
- Figure 30 Regional marketplace: Key takeaways
- Figure 31 Regional outlook, 2021 & 2030
- Figure 32 North America Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 33 U.S. Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 34 Canada Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 35 Europe Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 36 U.K. Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 37 Germany Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 38 Italy Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 39 Spain Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 40 France Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 41 Russia Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 42 Asia Pacific Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 43 Japan Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 44 Australia Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 45 China Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 46 India Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 47 Singapore Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 48 Latin America Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 49 Brazil Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 50 Mexico Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 51 Argentina Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 52 MEA Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 53 South Africa Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 54 Saudi Arabia Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
- Figure 55 UAE Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.